FluidForm Bio™, announced that it has named Jonathan Paris as general counsel and head of corporate strategy, Naomi Phaneuf as chief marketing officer, and Alex Lenz as vice president of people & business operations

FluidForm Bio, a leader in developing life-like human tissue to treat disease, shares recent advancements in building human cardiac tissues using FRESH™ 3D bioprinting.

FluidForm’s CDDP is the first tool to give actionable, translationally relevant signals at the critical juncture of lead selection and lead optimization.

Amgen’s research site in Burnaby, British Columbia, Canada, is working to build human immune system models that can help predict immune reactions to medicines in development.

FluidForm, a leader in the field of recreating human tissue to radically transform drug discovery, surgical repair, and replacement, today announced an investment from Hackensack Meridian Health and its Bear’s Den innovation program.

FluidForm, a leader in the field of human tissue for research, repair, and replacement, signed an agreement with Ethicon, Inc., a member of the Johnson & Johnson Medical Devices Companies, to develop 3D Bioprinted applications using FluidForm’s patented FRESH technology.

CTO Adam Feinberg named to 3D Natives Most Influential Personalities in Additive Manufacturing

Wired writes about research at Carnegie Mellon printing a full sized heart model using FRESH

Fast Company’s recognition of companies with “world-changing” ideas today was timely and symbolic. As the world navigates a way forward, Fast Company and others demonstrate that the show must and will go on. World-changing ideas cannot wait.

NIH Director’s blog reviewed the Science paper and the promise of FRESH printing

Scientists have taken a major step closer to being able to 3D bioprint functional organs, after researchers devised a method of rebuilding components of the human heart, according to a study published in the August 2nd edition of Science.

CTO Adam Feinberg speaks at the World Economic Forum

USPTO highlights FRESH in their Science of Innovation series

NIH Director’s blog reviewed the Hinton paper demonstrating a new way to print biologic scaffolds